Anika Therapeutics (ANIK) Finished Goods (2011 - 2018)

Anika Therapeutics (ANIK) has 8 years of Finished Goods data on file, last reported at $4.6 million in Q3 2018.

• Finished Goods for Q3 2018 came in at $4.6 million, down 20.31% year-over-year; the trailing twelve-month figure through Sep 2018 was $4.6 million (down 20.31% YoY), and the FY2017 annual result was $4.7 million, up 3.02% from the prior year.
• Finished Goods declined to $4.6 million in Q3 2018 per ANIK's latest filing, from $5.2 million in the prior quarter.
• Over five years, Finished Goods peaked at $6.8 million in Q1 2018 and troughed at $3.1 million in Q1 2015.
• A 5-year average of $4.6 million and a median of $4.6 million in 2018 frame the typical range for Finished Goods.
• The sharpest annual moves came in 2014 and 2015: Finished Goods jumped 147.88% in 2014, then plunged 41.93% in 2015.
• A 5-year view of Finished Goods shows it stood at $3.2 million in 2014, then grew by 9.3% to $3.5 million in 2015, then increased by 29.64% to $4.5 million in 2016, then gained by 3.02% to $4.7 million in 2017, then slipped by 0.81% to $4.6 million in 2018.
• Business Quant data shows ANIK's Finished Goods at $4.6 million in Q3 2018, $5.2 million in Q2 2018, and $6.8 million in Q1 2018.